Tesamorelin
Sourcing GuideSourcing Tesamorelin from research-grade vendors requires the QC framework that governs any peptide procurement: certificate of analysis review, lot-specific verification, third-party laboratory issuance, and — critically — endotoxin testing for injectable material. An FDA-approved long-chain GHRH analogue used for HIV-associated lipodystrophy and notable for its consistent effect on visceral adipose reduction. The three-tier vendor market (pharmaceutical-grade compounded, reputable research-grade, grey-market) is described below.
Key Takeaways
Procurement lens: Tesamorelin sourcing requires lot-specific COA, HPLC purity ≥98%, mass spec confirmation matching 5135 Da. Mechanism: Modified GHRH (1-44) sequence with an N-terminal trans-3-hexenoic acid that confers resistance to DPP-4 cleavage. Storage: lyophilised at -20°C for 18-24 months; reconstituted at 4°C for 14-28 days. Vendor tier: pharmaceutical-grade compounded > reputable research-grade > grey-market (3-5x cost differential; quality differential substantially larger). Sourcing-validated stack partners: BPC-157, TB-500, GHK-Cu.
Modified GHRH (1-44) sequence with an N-terminal trans-3-hexenoic acid that confers resistance to DPP-4 cleavage. Stimulates pituitary GH release, raising IGF-1 and producing marked reduction in visceral adipose tissue with relative sparing of subcutaneous fat. Quality control discipline for Tesamorelin starts with mechanism understanding: which assays detect counterfeits, which impurities matter for the intended use, and which storage conditions preserve activity. The subsections work through HPLC purity, COA evaluation, reconstitution protocol, and vendor selection.
Reconstitution and storage protocols
Tesamorelin is typically supplied lyophilised in glass vials for reconstitution with bacteriostatic water. Standard reconstitution: dissolve at 1–2 mg/mL, store reconstituted material at 4°C, and use within 14–28 days. Avoid freeze-thaw cycles of reconstituted material. Lyophilised storage at −20°C extends shelf life to 18–24 months for most peptides in this class.
Vendor tier comparison and price discipline
Three vendor tiers operate in the Tesamorelin market: pharmaceutical-grade compounded prescription (physician-supervised, full COA, ICP-MS where relevant, highest cost), reputable research-chemical vendors (full COA, lot-specific, mid-tier cost), and grey-market unverified sources (template or absent COA, unverifiable supply chain, lowest cost). The price differential between tiers is roughly 3–5x; the quality differential is substantially larger and concentrated in the bottom tier.
HPLC purity and analytical identity
Minimum acceptable HPLC purity for Tesamorelin is ≥98% in research-grade material. Mass spec confirmation should show the characteristic m/z of 5135 (M+H)+. Contaminant peaks above 1% in the HPLC trace warrant quantification on the COA and — ideally — structural identification of the major impurities.
Pharmaceutical-grade compounded Tesamorelin is the lowest-risk sourcing path for cold chain use where the route permits, particularly for users with clinical supervision. Research-grade material from accredited vendors is the practical alternative; grey-market sourcing is not appropriate for this application.
Sourcing Tesamorelin for lot variability use requires the same QC discipline as any peptide procurement: lot-specific COA, HPLC purity ≥98%, mass spec confirmation, endotoxin testing for injectable routes. Application-specific use does not relax the sourcing standard.
For users targeting pricing analysis, the sourcing question is whether the chosen vendor consistently delivers analytical-spec material across lots. Repeated re-orders from the same vendor with mid-cycle COA spot-checks is the procurement pattern that catches lot drift before it affects results.
Pharmaceutical-grade compounded Tesamorelin is the lowest-risk sourcing path for coa review use where the route permits, particularly for users with clinical supervision. Research-grade material from accredited vendors is the practical alternative; grey-market sourcing is not appropriate for this application.
| Goal | Route | Dose | Cycle |
|---|---|---|---|
| Standard protocol | SubQ | 1-2 mg | 8–12 weeks on / 4 weeks off |
| Conservative starter | SubQ | 1-2 mg | 4–6 weeks initial cycle |
| Sourcing Guide focus | SubQ | 1-2 mg | 1x daily SubQ |
| Maintenance phase | SubQ | 1-2 mg | Ongoing with periodic pauses |
Dose timing for Tesamorelin is important relative to food and training given the short half-life. Consistency through the cycle is more important than the precise clock time of individual doses. Fasted dosing produces stronger GH pulses; meal-paired dosing blunts the response.
Tesamorelin stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from experienced peptide buyers.
- Tesamorelin + BPC-157: Upregulates VEGFR2 to promote angiogenesis and activates the FAK-paxillin pathway for accelerated tissue repair. Pairs naturally with Tesamorelin's mechanism in sourcing / quality / procurement protocols.
- Tesamorelin + TB-500: Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool. Pairs naturally with Tesamorelin's mechanism in sourcing / quality / procurement protocols.
- Tesamorelin + GHK-Cu: GHK chelates copper(II) and acts as a transcriptional modulator: published microarray data show it influences over 4,000 human genes including resetting expression patterns toward younger cellular phenotypes. Pairs naturally with Tesamorelin's mechanism in sourcing / quality / procurement protocols.
- Tesamorelin + Ipamorelin: Highly selective GHSR1a agonist. Pairs naturally with Tesamorelin's mechanism in sourcing / quality / procurement protocols.
Site reactions, arthralgia, fluid retention. IGF-1 elevation; monitor. Pregnancy contraindicated.
Lens-specific safety considerations for sourcing / quality / procurement use of Tesamorelin: Site reactions, arthralgia, fluid retention. IGF-1 elevation; monitor. Pregnancy contraindicated. Additional sourcing / quality / procurement monitoring at baseline and 6–8 week follow-up is appropriate.
| Compound | Profile | Onset | Best For |
|---|---|---|---|
| Tesamorelin | Stabilised GHRH analogue | ~30 min | Sourcing Guide |
| BPC-157 | Stable gastric pentadecapeptide | ~4 hr (oral) | Accelerated tendon, ligament, and gut tissue repair via VEGFR2-driven angiogenesis and FAK-paxillin signalling |
| TB-500 | Synthetic thymosin β4 fragment | ~2-3 days | A 17-amino-acid synthetic fragment of thymosin β4 with actin-sequestering activity — drives cell migration, tissue repair, and broad regenerative effects |
| GHK-Cu | Tripeptide-copper complex | ~30 min plasma | A naturally occurring tripeptide-copper complex that declines with age and is studied for its broad effects on wound healing, skin remodelling, and gene expression |
| Ipamorelin | Selective GHRP / ghrelin mimetic | ~2 hr | The most selective ghrelin-receptor agonist among the GHRPs — stimulates GH release with minimal effect on cortisol, prolactin, or appetite |
Reconstitution best practices?
Vendor red flags?
Pharmaceutical-grade versus research-grade?
Storage protocol?
What is the standard dosing protocol for Tesamorelin?
What route should I use for Tesamorelin?
Start a Tesamorelin Protocol
Alukard provides GMP-certified physician-supervised sourcing with GMP-certified Tesamorelin and Pharmaceutical-grade compounds with full COA documentation.
Get ProtocolQuick Facts
- Molecular weight
- 5135 Da
- Sequence length
- 44 aa
- Half-life
- ~30 min
- WADA
- Banned (S2)
- FDA
- Approved (Egrifta 2010 for HIV lipodystrophy)
Stack Partners
All sourcing / quality / procurement applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for Tesamorelin unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.
Start Your Sourcing / Quality / Procurement Protocol for Tesamorelin
Alukard provides GMP-certified physician-supervised sourcing with Pharmaceutical-grade compounds with full COA documentation.
HIPAA Compliant · GMP Certified · Physician Supervised